Peregrine Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-199,086
| Closed | -$3.83M | – | 350 |
|
|
2024
Q3 | $3.83M | Buy |
199,086
+427
| +0.2% | +$8.22K | 0.12% | 239 |
|
|
2024
Q2 | $4.08M | Buy |
198,659
+2,580
| +1% | +$53K | 0.12% | 242 |
|
|
2024
Q1 | $4.67M | Buy |
196,079
+46
| +0% | +$1.1K | 0.13% | 237 |
|
|
2023
Q4 | $4.24M | Sell |
196,033
-23,941
| -11% | -$517K | 0.13% | 236 |
|
|
2023
Q3 | $3.19M | Sell |
219,974
-13,764
| -6% | -$200K | 0.1% | 242 |
|
|
2023
Q2 | $4.89M | Buy |
+233,738
| New | +$4.89M | 0.13% | 240 |
|